Harrow, Inc. — Earnings Quality Grade F
HROW · Healthcare
Major red flags
Screening Summary
管理层信号
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
DSO 149 days, change -64 days YoY
AR growth -4.7% vs revenue growth 36.4%
Revenue 36.4%, CFFO 297.6%. Cash follows revenue
Expense Quality
Inventory 26.4% vs COGS 38.0%. Normal
CapEx growth -97.2% vs revenue 36.4%. Normal
SG&A/Gross Profit = 74.8%, exceeds 70%
Gross margin 75.1%, change -0.3pp. Stable
Cash Flow Quality
CFFO/NI = -8.54. Below 1.0
FCF $0.0B, FCF/NI = -8.32
Accruals ratio = -12.3%. Low accruals
Cash $0.1B covers only 29% of debt $0.3B
Balance Sheet Health
Goodwill+Intangibles $0.2B = 337% of equity. Over 50%
Debt/EBITDA = 5.9x (>4x). Interest coverage = 1.3x (<2x). Financial stress
Insufficient data
No write-off data
Acquisition Risk
FCF after acquisitions negative for 2/3 years
Goodwill+Intangibles change -6% YoY. Normal
Manipulation Score
M-Score = -3.05 (< -2.22). Unlikely manipulator
Beneish M-Score
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25